Biopharma startup Triumvira Immunologics raises $55M
August 28, 2020 at 09:09 AM EDT
The startup has developed a new technology to treat cancer patients. President and CEO Dr. Paul Lammers said human clinical trials are scheduled to begin next year. Check out how else he and his colleagues will spend their new funding round.
